SecBot SecBot
8-K ·Filed Sep 25, 2026

VTAK

Catheter Precision, Inc.
NEUTRAL
Impact 3/10
Horizondays Processed1mo ago SEC0001437749-26-031252
8-K context-dependent: Items 8.01
Actionable Insight • Neutral

The reverse split and ticker change are administrative; monitor for any subsequent business updates under the new name Flyte Aviation that could signal a strategic pivot.

DirectionNeutral
Confidencehigh
Horizondays
Latest settled — T+1d
VTAK ▼ -2.52% at T+1d
NEUTRAL call -2.52% · α vs SPY -2.34% · entry $0.1467 → $0.1430
Next anchor: T+5d due 25d ago
Latest observation: T+19 -5.00% FF3 residual α
Entry = T+0 close
Sep 25, 2026
via day close
T+1d
-2.52%
call -2.52% · α -2.34%
$0.1430
settled 29d ago
T+5d
Pending
due 25d ago
T+20d
Pending
due 4d ago
T+60d
Pending
in 8w

Price Chart

Loading chart...

Executive Summary

Catheter Precision, Inc. (VTAK) announced a name change to Flyte Aviation, Inc. and a 1-for-10 reverse stock split, effective October 5, 2026. The stock will trade under the new ticker VJET on the NYSE American. This is a routine corporate action with no financial data or operational catalyst provided.

Key Facts

  • Board approved name change to Flyte Aviation, Inc. and 1-for-10 reverse stock split on September 24, 2026.
  • Name change did not require stockholder approval; reverse split was approved by stockholders on April 15, 2026.
  • Effective at 12:01 a.m. ET on October 5, 2026; new ticker VJET and CUSIP 74933X 807.
  • No fractional shares issued; fractional holders receive pro rata proceeds from sale of aggregated shares.
  • Par value and authorized shares unchanged; proportionate adjustments to equity awards, warrants, and convertible securities.

Financial Impact

No financial figures provided; reverse split is a mechanical share consolidation with no change to market cap or enterprise value.

share countticker symbol

Risk Factors

  • Reverse splits often signal low stock price and potential delisting risk, though no delisting notice was filed.
  • No operational or financial rationale provided for the name change or split.

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001437749-26-031252
Document: 0001437749-26-031252-index-headers.html0001437749-26-031252
Document: 0001437749-26-031252-index.html0001437749-26-031252
Document: 0001437749-26-031252.txt0001437749-26-031252
23 reports for VTAK
Performance horizon
67% Hit rate @ T+5 4 of 6 directional calls Went positive at some point 6 of 6 best @ T+60▲ +82.93%Jun 22, 2026
Filters
Rows
Reports for VTAK — sortable, filterable
TypeNow
Oct 9, 2026
17d ago
8-K
BEARISH ★ 7/10
$1.00 $0.8200▲ +18.00%▲ +16.51%$0.6500 (+35.00%)
Oct 5, 2026
22d ago
Press Release
NEUTRAL ★ 2/10
$1.62 $1.00▼ −38.27%▼ −38.69%$0.6500 (−59.88%)
Oct 2, 2026
24d ago
8-K
NEUTRAL ★ 5/10
$1.62 $1.00▼ −38.27%▼ −38.69%$0.6500 (−59.88%)
Oct 2, 2026
24d ago
Press Release
NEUTRAL ★ 4/10
$1.62 $1.00▼ −38.27%▼ −38.69%$0.6500 (−59.88%)
Sep 28, 2026
29d ago
Press Release
NEUTRAL ★ 2/10
$0.1467awaiting T+5—$0.6500 (+343.08%)
Sep 25, 2026
4w ago
8-K
NEUTRAL ★ 3/10
$0.1467awaiting T+5—$0.6500 (+343.08%)
Aug 27, 2026
8w ago
Press Release
NEUTRAL ★ 4/10
$0.2027 $0.1966▼ −3.01%▼ −3.28%$0.6500 (+220.67%)
Aug 11, 2026
11w ago
Press Release
NEUTRAL ★ 2/10
$0.2900 $0.2229▼ −23.14%▼ −22.73%$0.6500 (+124.14%)
Aug 4, 2026
11w ago
Press Release
NEUTRAL ★ 3/10
$0.2760 $0.2930▲ +6.16%▲ +6.26%$0.6500 (+135.51%)
Jul 13, 2026
15w ago
EFFECT
BEARISH ★ 7/10
$0.6504 $0.5020▲ +22.82%▲ +21.87%$0.6500 (+0.06%)
Showing 10 of 23

US Market Status

Market Closed — Opens in 44m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Sep 25, 2026